Katsuyasu Saigo

2.5k citations

106 papers · 1.8k indexed · 1 hit paper · h-index 20

Co-authors: Shunichi Kumagai Seiji Kawano Kunihiro Nishimura Goh Tsuji Takashi Nakazawa Akio Morinobu M. Koshiba Yoshinori Kogata
Topics: Platelet Disorders and Treatments (18 papers)Acute Myeloid Leukemia Research (17 papers)Hemoglobinopathies and Related Disorders (10 papers)
Cited by: Hematology Rheumatology Genetics
Journals: Journal of Biological ChemistrySHILAP Revista de lepidopterologíaBlood
Partner nations: Japan United States Nigeria

In The Last Decade

Katsuyasu Saigo

105 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis

2007 587 citations Kunihiro Nishimura, Seiji Kawano et al. profile →

Peers

Countries citing papers authored by Katsuyasu Saigo

Since Specialization

Citations

This map shows the geographic impact of Katsuyasu Saigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuyasu Saigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuyasu Saigo more than expected).

Fields of papers citing papers by Katsuyasu Saigo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuyasu Saigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuyasu Saigo. The network helps show where Katsuyasu Saigo may publish in the future.

Co-authorship network of co-authors of Katsuyasu Saigo

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuyasu Saigo. A scholar is included among the top collaborators of Katsuyasu Saigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuyasu Saigo. Katsuyasu Saigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Labile iron, ROS, and cell death are prominently induced by haemin, but not by non-transferrin-bound iron 2021 ·Transfusion and Apheresis Science ·(unknown),(unknown),(unknown),Mari Kono,(unknown),(unknown),(unknown),Katsuyasu Saigo	12
2	After haemin treatment intracellular non-haem iron increases prior to haem oxygenase-1 induction: A study in human monocytic cell line THP-1 2019 ·Transfusion and Apheresis Science ·(unknown),(unknown),Mari Kono,(unknown),(unknown),(unknown),(unknown),Hirohide Sawada,Katsuyasu Saigo	6
3	Haemin-induced cell death in human monocytic cells is consistent with ferroptosis 2018 ·Transfusion and Apheresis Science ·(unknown),Mari Kono,(unknown),(unknown),(unknown),(unknown),Hirohide Sawada,(unknown),Katsuyasu Saigo	56
4	CHANGE IN THE RATE OF POST-TRANSFUSION-TRANSMITTED INFECTION TEST ADMINISTRATION FOLLOWING BY INTRODUCTION OF AN ALERT SYSTEM IN AN ELECTRONIC MEDICAL RECORD 2012 ·Japanese Journal of Transfusion and Cell Therapy ·(unknown),(unknown),Makoto Hashimoto,(unknown),(unknown),Yutaka Takaoka,(unknown),Seiji Kawano,Katsuyasu Saigo,(unknown),T Sugimoto,(unknown)	2
5	FLT3/ITD Associated with an Immature Immunophenotype in PML-RARα Leukemia 2012 ·SHILAP Revista de lepidopterología ·Mariko Takenokuchi,Seiji Kawano,Yuji Nakamachi,(unknown),(unknown),Katsuyasu Saigo,E Tatsumi,Shunichi Kumagai	9
6	IMMATURE PLATELET FRACTION MEASURED USING THE AUTOMATED HEMATOLOGY ANALYZER XE-2100: A POSSIBLE PREDICTIVE MARKER FOR PLATELET RECOVERY AFTER CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION 2009 ·Japanese Journal of Transfusion and Cell Therapy ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Katsuyasu Saigo,(unknown),Yoshiyuki Kakehi,(unknown)	1
7	TWO CASES OF CEREBRAL VESSEL DISEASE FOLLOWING HIGH DOSE INTRAVASCULAR IMMUNOGLOBULIN THERAPY 2009 ·Japanese Journal of Transfusion and Cell Therapy ·(unknown),Katsuyasu Saigo,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	0
8	Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay 2009 ·Transfusion Medicine ·(unknown),Kouichi Kawamura,Yukihiro Tokumine,Nobukazu Araki,(unknown),(unknown),Hiroyuki Inaba,Katsuyasu Saigo,(unknown),Hitoshi Okazaki	8
9	DR negativity is a distinctive feature of M1/M2 AML cases with NPM1 mutation 2008 ·Leukemia Research ·(unknown),E Tatsumi,(unknown),Mariko Takenokuchi,Yuji Nakamachi,Seiji Kawano,Shunichi Kumagai,Katsuyasu Saigo,Toshimitsu Matsui,Takayuki Takahashi,Kenichi Nagai,Gunadi Gunadi,Hisahide Nishio,Hiroki Yabe,Shinichi Kondo,Yoshitake Hayashi	18
10	Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients 2008 ·Transfusion and Apheresis Science ·Katsuyasu Saigo,(unknown),(unknown),(unknown),Mariko Takenokuchi,Kunihiro Nishimura,T Sugimoto,Kosuke Sakurai,Makoto Hashimoto,Tomoko Yanai,Akira Hayakawa,Yasuhiro Takeshima,Tsutomu Nomura,Yoshitsugu Kubota,Shunichi Kumagai	36
11	Usefulness of Sequential Automated Analysis of Fragmented Red Blood Cells for the Differential Diagnosis of Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome following Allogeneic Hematopoietic Cell Transplantation 2005 ·PubMed ·Shion Imoto,Tohru Murayama,Kenichi Nagai,Norio Hirabayashi,Chiaki Tanaka,Mahito Misawa,(unknown),Ishikazu Mizuno,Tamio Koizumi,Kazuyoshi Kajimoto,Takayuki Takahashi,Hiroshi Hara,Shunichi Kumagai,Katsuyasu Saigo	4
12	Von Willebrand Factor-Cleaving Protease Activity Remains at the Intermediate Level in Thrombotic Thrombocytopenic Purpura 2005 ·Acta Haematologica ·T Sugimoto,Katsuyasu Saigo,(unknown),(unknown),(unknown),Hiroko Narita,(unknown),Shion Imoto,Tohru Murayama,Masanori Matsumoto,Yoshihiro Fujimura,Ryuichiro Nishimura,Tamio Koizumi,Shunichi Kumagai	1
13	Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors 2002 ·PubMed ·(unknown),Shunichi Kumagai,Ryukichi Ryo,(unknown),Noriko Kitamura,M. Koshiba,Katsuyasu Saigo	2
14	Evaluation of the optimal condition of blood sampling applied to the IMI (Immature Information) scattergram of the automated hematology analyzer SE-9000. 2001 ·Journal of the Japan Society of Blood Transfusion ·Tsutomu Nomura,Yoshitsugu Kubota,(unknown),Katsuyasu Saigo,Tomohiko Taminato	2
15	Tetrasomy 21 as the sole acquired karyotypic abnormality in acute myeloblastic leukemia 2001 ·Cancer Genetics and Cytogenetics ·(unknown),T Sugimoto,(unknown),E Tatsumi,Katsuyasu Saigo	2
16	B‐cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study 1999 ·British Journal of Haematology ·Chihiro Shimazaki,(unknown),Kazuho Shimura,Akio Okamoto,Ryoichi Takahashi,Hideyo Hirai,Yoshikazu Sudo,Eishi Ashihara,Yoko Adachi,Satoshi Murakami,Katsuyasu Saigo,Naohisa Fujita,Masao Nakagawa	62
17	Extramedullary tumor as presentation of leukemia: Establishment of a new human GPIIb- and GPIIIa-positive leukemia cell line 1994 ·Annals of Hematology ·(unknown),(unknown),(unknown),(unknown),Hirokazu Taniguchi,Hitoshi Sawada,(unknown),(unknown),Wataru Sugano,Katsuyasu Saigo,Nobuo Yamaguchi	3
18	Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen‐induced platelet aggregation 1992 ·American Journal of Hematology ·Ryukichi Ryo,(unknown),Wataru Sugano,(unknown),(unknown),Katsuyasu Saigo,Masashi Adachi,Nobuo Yamaguchi,Minoru Okuma	76
19	Histidine‐rich glycoprotein as a negative acute phase reactant 1990 ·American Journal of Hematology ·Katsuyasu Saigo,(unknown),Ryukichi Ryo,Nobuo Yamaguchi,Lawrence Leung	31
20	Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and it's clinical effectiveness 1988 ·Annals of Hematology ·Katsuyasu Saigo,Shunichi Shiozawa,Kazuko Shiozawa,(unknown),(unknown),Nobuo Yamaguchi,Hirotoshi Shibata,T Masaoka	10

About Katsuyasu Saigo

Katsuyasu Saigo is a scholar working on Hematology, Genetics and Immunology, having authored 106 papers that have together received 1.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (18 papers), Acute Myeloid Leukemia Research (17 papers) and Hemoglobinopathies and Related Disorders (10 papers). The work is most often cited by research in Hematology (609 citations), Rheumatology (521 citations) and Genetics (247 citations). Katsuyasu Saigo has collaborated with scholars based in Japan, United States and Nigeria. Frequent co-authors include Shunichi Kumagai, Seiji Kawano, Kunihiro Nishimura, Goh Tsuji, Takashi Nakazawa, Akio Morinobu, M. Koshiba, Yoshinori Kogata, Karen M. Kuntz and Daisuke Sugiyama. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact